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Znf131 is a member of the BTB/POZ family of transcription factors with roles in development and carcinogenesis. Like many members of this
protein family, Znf131 displays robust nuclear localization in cultured cells, but the mechanism(s) of Znf131 nuclear trafficking is unknown. Here,
we report the mechanism of Znf131 nuclear localization. Visual inspection of the Znf131 amino acid sequence revealed three basic regions (BR-1,
-2 and -3) with the potential to serve as nuclear localization signals (NLS). Of the three basic regions, only BR-1 functioned independently to
efficiently target heterologous β-gal-GFP fusion proteins to HeLa cell nuclei. However, a Znf131 truncation mutant containing BR-2 and BR-3
efficiently targeted heterologous β-gal-GFP fusion proteins to HeLa cell nuclei. Mutational analysis of full-length GFP-tagged Znf131 revealed
that loss of any one BR alone did not prevent Znf131 nuclear localization. This apparent redundancy in NLS activity was due to the fact that intact
BR-1 or BR-2 alone could target full-length Znf131 to nuclei. Consequently, simultaneous mutation of BR-1 and BR-2 abolished full-length
Znf131 nuclear localization. Therefore, BR-1 and BR-2 are functional NLSs for Znf131 and as such are designated NLS-1 and NLS-2. Finally,
wild type Znf131, and not a Znf131 NLS-defective mutant (NLS-1m/NLS-2m) interacted preferentially with the nuclear import receptor Importin-
α3 in vitro.
© 2006 Elsevier B.V. All rights reserved.Keywords: Znf131; Transcription factor; POZ-ZF; Nuclear import; NLS1. Introduction
The BTB/POZ (Broad complex, Tramtrack and Bric à brac/
Pox virus zinc finger) zinc finger proteins are members of a
rapidly growing family of transcription factors with established
roles in development and tumourigenesis [1,2]. The Cys2–His2
zinc finger is the most abundant type of zinc finger motif and is
found in many BTB/POZ (hereafter, POZ) proteins [3]. The
principal function of the C-terminal zinc finger domain of POZ
proteins is to mediate DNA binding whereas its N-terminal POZ
domain mediates protein–protein interactions [1,2,4]. The POZ
domain is a highly conserved hydrophobic region of approxi-
mately 120 amino acids that was first identified in the Droso-
phila Tramtrack (Ttk) and Broad Complex zinc finger proteins,
as well as in the pox virus and kelch gene products [1,2]. To
date, Drosophila POZ proteins have been associated with
nucleosome and chromatin remodelling, pattern formation and
metamorphosis [1,2].⁎ Corresponding author. Tel.: +1 905 525 9140x23765; fax: +1 905 522 6066.
E-mail address: danielj@mcmaster.ca (J.M. Daniel).
0167-4889/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2006.12.005The best characterized mammalian POZ proteins are Pro-
myelocytic Leukemia Zinc Finger (PLZF) and Lymphoma As-
sociated Zinc Finger3/B-Cell Lymphomas-6 (LAZ3/BCL-6).
PLZF is a 673 amino acid protein with nine C-terminal zinc
fingers whereas BCL-6 is a 706 amino acid oncoprotein
containing six zinc fingers [5]. PLZF and BCL-6 both form
homodimers and interestingly they also heterodimerize with
each other and other POZ-ZF proteins [5,6]. To date however,
the mechanism of nuclear localization for PLZF, BCL-6 and
most POZ proteins remains unknown, although the POZ domain
is thought to regulate the subnuclear localization of BCL-6 [7].
A large proportion of POZ proteins have been identified as
either transcriptional repressors or activators [8–10]. Transcrip-
tional repression by PLZF and BCL-6 involve recruitment of
nuclear co-repressors [11]. These co-repressors (NCoR, SMRT
and mSin3A) form a complex with Histone Deacetylases
(HDAC) at the promoter region of target genes and cause the
local formation of heterochromatin, which silences transcrip-
tion. However, not all POZ-ZF proteins repress transcription via
an HDAC-dependent mechanism. For example, the 714 amino
acid tumour suppressor HIC-1 (Hypermethylated in Cancer-1)
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domain in an HDAC-independent manner [12].
Previously, sixteen novel human zinc finger proteins were
identified as candidates in developmental and malignant
disorders [13]. One of the novel cDNAs identified was
Znf131 (Zinc Finger 131), a gene that mapped to human
chromosome 5p11–p12. Znf131 was subsequently character-
ized as a member of the POZ-ZF family of transcription
factors and found to be ubiquitously expressed. However
higher expression levels were noted in the brain, testis,
thymus, central nervous system and embryonic limb bud of
mice and humans [14]. This expression pattern suggests that
Znf131 may play a role in organogenesis and in the
development of the adult central nervous system [14]. Further
characterization of the human (ZNF131) and murine (Znf131)
genes revealed intra-exonic splicing of exon 4, subsequently
producing two isoforms of the protein [14]. Both isoforms
contain the amino-terminal POZ domain and zinc fingers at
their carboxy-termini. The murine long isoform has 619 amino
acids residues and contains five classical C2H2 zinc fingers
and one C2HC zinc finger, while the short isoform has 585
amino acids and possesses only four C2H2 zinc fingers and
one C2HC zinc finger [14].
Although most POZ-ZF proteins display robust nuclear
localization in cultured cells, the mechanism of nuclear
localization has only been determined for Kaiso, a unique
transcriptional repressor with bimodal DNA-binding properties
[8]. To determine whether the classical NLS-dependent
nuclear import pathway was the preferred means of nuclear
import for other POZ-ZF proteins and as a first step towards
understanding the cellular function of Znf131, we chose to
clarify Znf131's mechanism of nuclear import using an
established mutagenesis approach [15]. We identified and
characterized three basic regions within Znf131 (BR-1, BR-2
and BR-3) and found that two of these, BR-1 and BR-2,
served as Znf131 nuclear localization signals (NLS-1 and
NLS-2). One NLS is immediately downstream of the POZ
domain (NLS-1) and the other lies within the zinc finger
domain of Znf131 (NLS-2). Either one of these NLSs is
sufficient to target full-length Znf131 to cell nuclei. The
functionality of NLS-1 and NLS-2 was further demonstrated
by their ability to individually target a heterologous β-
galactosidase (β-gal)-green fluorescence fusion protein (GFP)
to nuclei. The requirement for the identified NLSs was further
confirmed by the loss of Znf131 nuclear localization following
the simultaneous mutation of NLS-1 and NLS-2. Additionally,
we demonstrate that Znf131 interacts in vitro with several
Importin-α nuclear import receptors (α2, α3 and α7),
although Znf131 exhibits preferential binding to Importin-α3.
2. Materials and methods
2.1. Cell culture
HeLa (Human cervical carcinoma) cells were purchased from ATCC and
cultured in Dulbecco's minimal essential medium (DMEM) (Hyclone)
supplemented with 4 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml
streptomycin (Invitrogen), 10% fetal bovine serum (Hyclone) and 0.5 μg/mlfungizone (Invitrogen). The cells were grown at 37 °C in a 5% CO2 humidified
incubator.
2.2. Plasmid constructs
The Znf131 deletion constructs were generated by PCR amplification of
various regions of the murine full-length short isoform (585 amino acids,
Accession #NP_082521). These cDNA fragments were then subcloned into the
pHM829 vector [15] which encodes β-gal and GFP at the 5′ and 3′ end
respectively. When expressed in mammalian cells, these constructs produced
various Znf131 fusion proteins tagged N-terminally to β-gal and C-terminally to
GFP. The PCR primers used in each reaction incorporated SacII and Xba1
restriction sites into the PCR products at the 5′ and 3′ ends respectively. An
exception was the POZ and ΔPOZ constructs which incorporated the Nhe1 and
SacII restriction sites. The primers used to perform the PCR amplifications were:
Znf131-POZ (bp 1-387), 5′-ACCGGCTAGCATGGAGGCTGAAGAGACG-3′
and 5′-ACCGCCGCGGTGAGTTTTCTTTGTTCCT-3′; Znf131-ΔPOZ (bp
388–1756), 5′-ACCGGCTAGCGCTCCATTAGAGGAAAAC-3′ and 5′-
ACCGCCGCGGTTCTAAAACCGGCAGAGA-3′; Znf131-entire ZF (bp
703–1756), 5′-CTACCGCGGTGTGCATCTGACCCC-3′ and 5′-TCCTCTA-
GACACATGCACTTTCCCAAC-3′; Znf131-BR-2-BR-3 (bp 847–1089) 5′-
CTACCGCGGGAAGGTGGAGTAAGT-3′ and 5′-TCCTCTAGAACA-
GACCTGGCATTC-3′. Restriction sites are underlined. The PCR products
were ethanol precipitated, digested and ligated into the appropriate vectors. To
analyse the putative NLSs individually, oligonucleotides corresponding to the
putative NLS's were annealed and ligated into the pHM829 vector. Each
construct was confirmed by automated fluorescence sequencing at the MOBIX
Facility (McMaster University). The GST-Importin-α constructs were described
previously [16,17] and were a kind gift from Dr. Ilkka Julkunen (National Public
Health Institute, Helsinki, Finland).
2.3. Site-directed mutagenesis
The putative NLS double point mutations were made using the full-length
Znf131 short isoform as template and the Quikchange XL Site-Directed
Mutagenesis Kit (Stratagene) according to themanufacturer's protocol. Themutants
were then subcloned into the pEGFP-C1 or pHM829 vectors to create the various
Znf131 constructs. Eachmutant was confirmed by sequencing (MOBIX,McMaster
University). The primers employed incorporated the desired mutations and were as
follows: BR-1m, 5′-GGAAAAAATGAGGCAGCTGCTAGAAAGAATGC-3′







Prior to transfection, HeLa cells were seeded onto coverslips in 6-well dishes
and incubated for at least 12 h until the cells were approximately 50-70%
confluent. All transfections were performed using the ExGen-500 reagent (MBI
Fermentas). For each construct, 2 μg of plasmid DNA was diluted in 150 mM
NaCl and mixed gently before 6 μl of ExGen-500 reagent was added. The
mixture was gently vortexed, and incubated without disturbing at RT for 15 min
to allow reagent/DNA complex formation. The complex was added drop-wise to
the cells in fresh serum-supplemented DMEMmedia before incubating the cells
for 3 h at 37 °C with 5% CO2, after which the reagent was aspirated and the cells
washed twice with 1× PBS. The cells were then incubated for 18–24 h in
supplemented DMEM medium before fixation in 4% paraformaldehyde or
100% methanol.
2.5. Immunofluorescence microscopy
The subcellular localization of endogenous Znf131 was analysed by
immunostaining. HeLa cells were seeded onto coverslips 1 day before assaying
at a confluency of 70–80%. Briefly, the cells were washed twice with 1× PBS
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non-fat milk-PBS at RT for 10 min, Znf131 mouse polyclonal antibody
(Abnova, Taiwan) was added at 1:300 dilution in 3% milk-PBS and incubatedFig. 1. Subcellular localization and expression of Znf131. (A) Immunofluorescen
antibody revealed that endogenous Znf131 localized primarily to the nuclei of
immunoprecipitating myc-Znf131 (∼115 kDa) from HeLa lysate using both myc- and
transfected cells (lane 2 and 4). (C) Endogenous Znf131 (∼94 kDa) was also immuno
representation of the Znf131 deletion mutants used to identify the NLSs. Each mutant
fused N-terminally to GFP localized exclusively to HeLa nuclei. The β-gal-SV4
exclusively to the nucleus, while the negative control β-gal-GFP fusion protein rem
Znf131 NLS, two (ΔPOZ and ZF) demonstrated strong nuclear localization. This res
one functional NLS resides downstream of the POZ domain and within the zinc fi
Bars, 10 μm.for 30 min at RT. After washing the cells 3× for 2 min each in PBS and briefly
immersing in 3% milk-PBS, Alexafluor 594-conjugated goat anti-mouse
secondary antibody (Molecular Probes, Eugene, Ore) was added at a dilutionce analysis of endogenous Znf131 using a mouse polyclonal Znf131-specific
HeLa cells. (B) The specificity of the Znf131 antibody was confirmed by
Znf131- specific antibodies (lanes 1 and 3), but not from negative control mock
precipitated from HeLa lysate using the Znf131-specific antibody. (D) Schematic
was fused N-terminally to β-gal and C-terminally to GFP. (E) Full-length Znf131
0-NLS-GFP fusion protein was used as a positive control and also localized
ained cytoplasmic. (F) Of the three Znf131 truncation mutants used to map the
ult suggests the POZ domain lacks nuclear localization activity and that at least
nger domain. All results are representative of at least three independent trials.
549N.S. Donaldson et al. / Biochimica et Biophysica Acta 1773 (2007) 546–555of 1:1000 in 3%milk along with diluted Hoechst (1:200). The cells were washed
3× with PBS and the coverslips mounted onto glass slides using Aqua
Polymount (Polysciences Inc. Warrington, PA) before imaging using a Zeiss
Axiovert 200 inverted fluorescent microscope.
The subcellular localization of the Znf131 mutant fusion proteins were
analysed by fluorescence microscopy approximately 24 h after transfecting the
cells. Briefly, the cells were washed twice in 1× cold PBS and fixed with 4%
paraformaldehyde (pH 7.4) or 100%methanol for 15 min at 4 °C. The cells wereFig. 2. Identification of Znf131 NLS sequences. (A) Visual inspection of the Znf131
conserved in diverse species, with the potential to serve as NLSs. (B) BR-1 efficiently
BR-3 peptides targeted the heterologous β-gal-GFP fusion proteins to the nucleus whe
of β-gal-BR-1m-GFP fusion protein, bearing a double point mutation in the BR-1 p
both BR-2 and BR-3 localized predominantly to HeLa cell nuclei, raising the poss
mutation in BR-2 of the β-gal-297–380-GFP construct abolished BR-2 functionality
double point mutation in BR-3 of the β-gal-297–380-GFP construct had no effect, i.e.
2 was not acting in concert with BR-3 but required other amino acids in the zinc fin
construct resulted in nuclear exclusion of the fusion protein (iv). Bars, 10 μm.then washed twice with 1× PBS and stained in the dark with diluted Hoechst for
10 min at room temperature. The cells were washed twice with 1× PBS and once
with distilled water before the coverslips were mounted and imaged as above.
2.6. Immunoprecipitation and immunoblot analysis
HeLa cells were plated into 100 mm dishes to achieve a confluency of
∼70% at the time of transfection. All transfections were performed withamino acid sequence revealed three basic regions (BR-1, -2, -3) that are highly
targeted a β-gal-GFP fusion protein to the nucleus. In contrast, neither BR-2 nor
n tested individually. (C) The functionality of BR-1 was confirmed by the failure
eptide, to localize to cell nuclei. (D) A Znf131 deletion construct encompassing
ibility that these two putative NLSs were acting in concert (i). A double point
and resulted in cytoplasmic localization of the fusion protein (ii). In contrast, a
the fusion protein localized efficiently to cell nuclei (iii). This suggested that BR-
ger domain. Simultaneous mutation of BR-2 and -3 in the β-gal-297–380-GFP
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Znf131 expression construct. Twenty hours post transfection the cells were
washed twice with 5 ml of PBS (pH 7.4) and incubated on ice for 15 min with
lysis buffer (0.5% NP-40, 50 mM Tris, 150 mM NaCl, 1 mM phenylmethyl-
sulfonyl fluoride, 5 μg/ml leupeptin, 2 μg/ml aprotinin, 1 mM sodium
orthovanadate and 1 mM EDTA). After harvesting, the cells were placed in
cold eppendorf tubes and centrifuged at 14,000 rpm for 5 min at 4 °C. The
supernatants were collected and the lysates quantitated by Bradford assay.
Equal amounts of total protein were immunoprecipitated with either 4 μl of
anti-GFP polyclonal antibody (Clontech), 2.5 μg of anti-myc monoclonal
(Invitrogen), 2 μl of anti-Znf131 polyclonal or 4 μg of anti-KT3 monoclonal
antibodies. The immune complexes were then separated by sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and the proteins
were transferred to nitrocellulose membrane using a Hoeffer semi-dry transfer
apparatus (Amersham/Pharmacia). The membranes were blocked at room
temperature with 3% milk/TBS (pH 7.4) and incubated at 4 °C overnight with
anti-GFP monoclonal antibody (Clontech) at 1:1000 dilution or anti-Znf131
polyclonal antibody at 1:300 dilution. The membranes were washed five times
with TBS for 5 min each and incubated at room temperature for 2 h with
horseradish-peroxidase-conjugated donkey anti-mouse secondary antibody at
1:40,000 in 3% milk. The membranes were washed as above and processed
with enhanced chemiluminescence (Amersham/Pharmacia) according to the
manufacturer's protocol.
2.7. In vitro transcription and translation (IVTT) and GST-pull down
interaction assays
Sp6-promoter driven expression of wild type and NLS-defective Znf131
constructs was achieved using the TnT Coupled Transcription and Translation
kit as per the manufacturer's protocol (Promega). Each IVTT product was
analysed via 7% SDS-PAGE and subsequently used to perform the GST-pull-
down assay as described previously [8].
3. Results and discussion
3.1. Analysis of Znf131 subcellular localization
Although most known POZ-ZF proteins display predomi-
nant nuclear localization, their mechanisms of nuclear localiza-
tion are largely unknown. The main exception thus far is Kaiso,
which we previously demonstrated contains a classical NLS and
interacts directly with Importin-α2 [8]. However, it was unclear
whether use of classical NLS-dependent nuclear import path-
ways was common to all or most POZ-ZF proteins, or whether
some employed more complex mechanisms of nuclear entry.
First, to confirm the subcellular distribution of Znf131 and
verify that like other POZ-ZF proteins, Znf131 localized to
nuclei, we immunostained HeLa cells and determined that
endogenous Znf131 is indeed nuclear (Fig. 1A). To confirm the
specificity of our mouse polyclonal anti-Znf131 antibody, myc-
tagged Znf131 was expressed in HeLa cells, and 24 h post-
transfection the lysate was subjected to immunoprecipitationFig. 3. Nuclear localization of full-length Znf131. (A) Schematic representation o
localizations. (B) HeLa cells were transfected with the full-length GFP-tagged Znf131
GFP polyclonal antibody. The proteins were resolved by SDS-PAGE, and Wester
expressed efficiently in this cell line. (C) Point mutations in individual basic regions
Simultaneous mutation of BR-1, -2 and -3 abolished the nuclear localization of Znf
Znf131. (E, i) Simultaneous mutation of BR-1 and BR-2 resulted in cytoplasmic ret
Znf131 to HeLa nuclei. (E, ii) Simultaneous mutation of BR-1 and BR-3 resulted
sufficient to target Znf131 to nuclei. (E, iii) Simultaneous mutation of BR-2 and BR-
BR-1 alone can also target Znf131 to nuclei. These findings confirm the functionalitwith anti-myc mAb and anti-Znf131 pAb. Western blot analysis
with Znf131-specific pAb confirmed the presence of myc-
Znf131 (∼115 kDa) in both the anti-myc and anti-Znf131
immunoprecipitates (Fig. 1B, lanes 1 and 3), but not in
immunoprecipitates from mock-transfected HeLa cells (Fig. 1B,
lanes 2 and 4). In addition, endogenous Znf131 was success-
fully immunoprecipitated from HeLa whole cell lysates and
subjected to SDS-PAGE and Western blot analysis with anti-
Znf131 pAb (Fig. 1C). These data demonstrate the specificity of
the Znf131-specific antibody used in this study.
As a first step towards mapping the Znf131 NLS we first
generated a GFP-Znf131 expression construct encoding the
short isoform of murine Znf131 fused N-terminally to enhanced
green fluorescence protein (eGFP, hereafter GFP) (Fig. 1D).
Following transient transfection, GFP-Znf131 localized exclu-
sively to the nuclei of HeLa cells, consistent with localization of
endogenous Znf131 (Fig. 1E i). Similar results were also
observed in Cos-1 and NIH 3T3 cells (data not shown).
3.2. Znf131 possesses three putative NLSs downstream of its
POZ domain
The strong nuclear localization of Znf131 led us to postulate
that Znf131 possessed at least one NLS to mediate its active
nuclear entry. To detect NLS activity in Znf131, we generated
three murine Znf131 deletion mutant constructs (Fig. 1D,
schematic; β-gal-POZ-GFP, β-gal-ΔPOZ-GFP, β-gal-ZF-GFP)
fused N-terminally to β-galactosidase and C-terminally to GFP.
In this established system for NLS identification [15], β-
galactosidase adds bulk to small polypeptides and prevents
passive nuclear diffusion, while GFP allows monitoring the
subcellular localization of the fusion proteins by fluorescence
microscopy. Controls for this assay included the β-gal-SV40-
NLS-GFP fusion protein, which localized robustly to nuclei,
and the β-gal-GFP fusion protein, which localized exclusively
to the cytosol (Fig. 1E ii, iii). When the β-gal-POZ-GFP
construct was tested in HeLa cells, predominant cytoplasmic
localization of the fusion protein was observed (Fig. 1F i).
However, when the ΔPOZ-GFP and β-gal-ZF-GFP expression
constructs were assayed, robust and reproducible nuclear
localization of the truncated Znf131 fusion proteins was
observed (Fig. 1F ii, iii). This suggested that, (1) the Znf131
POZ domain lacks NLS activity, and (2) at least one functional
NLS resides within the ZF domain.
Visual inspection of the Znf131 amino acid sequence revealed
the presence of three basic regions (BR-1, BR-2 and BR-3) with
the potential to serve as monopartite NLSs (Fig. 2A). BR-1f full-length Znf131 and mutant constructs and summary of their subcellular
constructs and equal amount of total protein was immunoprecipitated with anti-
n blotted with anti-GFP monoclonal antibody. All the constructs tested were
(BR-1, -2 or -3) did not affect the nuclear localization of full-length Znf131. (D)
131, indicating that there are no other functional nuclear localization signals in
ention of full-length Znf131, confirming that an intact BR-3 alone cannot target
in nuclear localization of full-length Znf131, suggesting that an intact BR-2 is
3 resulted in nuclear localization of full-length Znf131, suggesting that an intact
y of BR-1 and BR-2 as NLSs in the context of full-length Znf131. Bars, 10 μm.
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domain while BR-2 (VSKKQRTGKKIH, a.a. 300–311) and BR-3
(GAKKGRKKLY, a.a. 366–375) are located within the zinc finger
domain. More precisely, BR-2 is located between zinc fingers 1
and 2, while BR-3 is positioned between zinc fingers 3 and 4 (Fig.
1D). Analysis of Znf131 amino acid sequences from various
species further revealed that the three putative NLSs were highly
conserved (Fig. 2A), suggesting that these sequences could
potentially regulate Znf131 nuclear import.
To determine whether any of these three putative Znf131
basic sequences (i.e. BR-1, BR-2 or BR-3) possessed NLS
activity, each sequence was individually fused to β-gal-GFP to
evaluate its ability to direct the nuclear localization of this
heterologous fusion protein. Interestingly, the β-gal-BR-1-GFP
fusion protein was targeted predominantly to the nuclei of HeLa
cells, while the β-gal-BR-2-GFP and β-gal-BR-3-GFP fusion
proteins remained cytosolic over repeated trials (Fig. 2B i, ii,
iii). To confirm the NLS functionality of BR-1, we created a
double point mutation (KK143/144AA) within BR-1 and found
that this mutation abrogated its ability to target the heterologous
β-gal-GFP fusion protein to nuclei (Fig. 2C). This finding also
confirmed the need for these two basic lysine residues for BR-1
to possess NLS activity. The failure of BR-2 and BR-3 to
individually target the heterologous β-gal-GFP protein to nuclei
was surprising in light of the high conservation of BR-2 and
BR-3 across species. We therefore questioned whether BR-2
and BR-3 formed an atypical bipartite NLS. To test this
hypothesis, we generated a construct encompassing BR-2 and
BR-3 (β-gal-297–380-GFP). As seen in Fig. 2D i, this construct
was efficiently localized to HeLa nuclei, supporting our
hypothesis that BR-2 and BR-3 may act in concert to mediate
Znf131 nuclear import. However, when we tested a mutant
containing an intact BR-2 but mutated BR-3, this Znf131
deletion mutant retained its ability to localize to HeLa nuclei
(Fig. 2D iii). In contrast, the converse deletion mutant (intact
BR-3, mutant BR-2) exhibited a predominantly cytoplasmic
localization (Fig. 2D ii). These data strongly suggested that BR-
2 and BR-3 did not form a bipartite NLS, and reinforced that
BR-3 did not play an important role in Znf131 nuclear
localization.
3.3. NLS-regulated nuclear localization of full-length Znf131
To determine the relevance of the basic regions as putative
NLSs in the context of the full-length Znf131, we generated a
panel of Znf131 point mutant constructs (Fig. 3A). Double point
mutations (the first two lysines to alanines) were created within
each individual BR (-1, -2 or -3) of full-length GFP-Znf131.
Although BR-2 and -3 did not individually target the
heterologous β-gal-GFP fusion protein to cell nuclei (see Fig.
2B ii iii), we tested full-length Znf131 constructs possessing
double point mutations in each of these putative NLSs to
determine whether in the context of the full-length Znf131 they
possessed NLS activity. First, to verify that the GFP-Znf131
fusion proteins were intact, and that the observed results were
due to full-length Znf131 and not cleaved GFP moieties,
immunoprecipitation and western blot analyses were performedusing GFP-specific antibodies (Fig. 3B). All constructs tested
were expressed at the expected molecular weight of ∼124 kDa.
Surprisingly, as seen in Fig. 3C, none of these individual
mutations had a significant effect on Znf131 nuclear targeting,
as all three Znf131 point mutants localized efficiently to HeLa
cell nuclei. This suggested that perhaps BR-1 and BR-2 were
acting redundantly and compensating for each other in the
various mutants. It was also possible that these putative NLS
sequences acted in a combinatorial manner to target Znf131 to
the nuclear compartment or that another unique NLS sequence
existed in Znf131. However, this latter alternative was
disproved when we generated a construct harboring simulta-
neous point mutations in all three basic regions that represented
putative NLSs. As seen in Fig. 3D, the BR-1m, -2m, -3m GFP-
Znf131 protein localized primarily to the cytoplasm which
suggested that no other functional nuclear localization signals
regulate Znf131 nuclear translocation. The subcellular localiza-
tion of each full-length construct was quantified and the results
summarized in Table 1.
To further clarify the mechanism of Znf131 nuclear
localization, and to determine the necessity of BR-1 and -2
for Znf131 nuclear localization, we created Znf131 mutants
bearing mutations in various combinations of the identified
putative NLSs (Fig. 3A). When BR-1 and -2 were
simultaneously mutated, we observed cytoplasmic retention
of Znf131 (Fig. 3E i). This is consistent with our earlier
finding that BR-3 alone does not target Znf131 to nuclei. In
contrast, when BR-1,3 or BR-2,3 were simultaneously
mutated in the context of full-length Znf131, the mutant
Znf131 proteins localized predominantly to cell nuclei (Fig.
3E, ii and iii). The nuclear localization of the BR-2,3 mutant
protein (with an intact BR-1) was consistent with the strong
nuclear localization activity of BR-1 (see Fig. 2B). Likewise,
the nuclear localization of the BR-1,3 mutant (with an intact
BR-2) was consistent with the nuclear localization observed
with our β-gal-BR-2-BR-3m-GFP construct of Fig. 2D iii, but
inconsistent with our earlier finding that the BR-2 peptide was
unable to target the heterologous β-gal-GFP to nuclei (Fig. 2B
ii). One possible explanation for this discrepancy is that the
β-gal-BR-2-GFP fusion may adopt a conformation that rendered
BR-2 inaccessible to import receptors in the context of the
heterologous protein. Another alternative is that the peptide
sequence tested using the heterologous β-gal-GFP fusion
protein approach required additional N- and/or C-terminal
residues to constitute the functional NLS signal. To address
the latter hypothesis, we generated three additional mutants
(β-gal-BR-2-L-GFP, β-gal-BR-2-ZF2-GFP, and β-gal-BR-2-
Ext-GFP, Fig. 4A) containing BR-2 flanked C-terminally with
2, 24 and 55 amino acids respectively. Of these, only β-gal-
BR-2-Ext-GFP, containing the intact BR-2 as well as zinc
fingers 2 and 3, was targeted to nuclei (Fig. 4B i). Thus,
Znf131 BR-2 appears to require adjacent zinc fingers 2 and 3,
which may promote a conformation amenable to recognition
by Importin-α import receptors. The necessity of zinc finger
DNA-binding domains for nuclear localization is not unpre-
cedented and has been noted for other DNA-binding proteins
such as NGFI-A, PacC, Erythroid Krüppel-like Factor and
Table 1
Quantitation of cells exhibiting different subcellular localization of full length
Znf131 NLS mutants
Construct Nuclear (%) Cytoplasmic (%) Nuclear and
cytoplasmic (%)
GFP-Znf131 89.5±1.5 1±1 9.5±0.5
GFP-Znf131-BR-1m 85.5±1.5 0.5±0.5 14±1
GFP-Znf131-BR-2m 84±4 0 16±4













Each full-length Znf131 construct was scored blindly as predominantly nuclear,
cytoplasmic, or both nuclear and cytoplasmic. Each construct was tested in three
independent trials and scored at least twice. The values are expressed as the
mean of these experiments±s.d.
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function individually as an NLS in the context of full-length
Znf131 (Fig. 3E ii).Fig. 4. Mapping of the BR-2 domain. (A) Schematic representation of Znf131 mu
subcellular localization of each fusion protein is summarized at the right. (B) Subcell
along with zinc finger 2 and 3 serve as an NLS.Since the individual point mutations in BR-1 or -2 of the full-
length protein resulted in the nuclear import of Znf131, whereas
the simultaneous mutation of BR-1 and -2 caused exclusive
cytoplasmic localization of Znf131 (Fig. 3E i), we conclude that
(1) BR-3 does not play a role in regulating Znf131 nuclear
import and (2) that minimally, an intact BR-1 and/or BR-2 are
required for efficient Znf131 nuclear localization. Due to the
strong evidence of NLS activity for BR-1 and BR-2, we
therefore re-designate these basic regions of Znf131 as NLS-1
and NLS-2, respectively.
3.4. Znf131 binds Importin-α receptors in vitro
Importin-α proteins interact directly with NLSs of import
cargoes and facilitate their nuclear translocation [23]. To
investigate whether Znf131 interacts directly with Importin-α
import receptors for nuclear trafficking, we performed in vitro
GST-pulldown experiments using purified GST-importins (α2,
α3, α5 and α7, Fig. 5A) and in vitro transcribed and translated
(IVTT) wild type or NLS-defective Znf131. Wild type Znf131
interacted reproducibly with each immobilized GST-importin-α
fusion protein, but not to immobilized GST alone (Fig. 5B).
However, Znf131 bound strongly to GST-importin-α3, and to atant constructs used to fine-map the NLS encoded by the BR-2 domain. The
ular localization of various Znf131 mutants demonstrate that the BR-2 sequence
Fig. 5. Znf131 interacts directly with importin-α receptors. (A) Recombinant
GST, GST-importin-α2, -α3, -α5, and -α7 were expressed in and purified
from E. coli, prior to separation via SDS-PAGE and the resulting gel stained
with Coomassie blue. (B) To determine whether Znf131 interacts with
importin receptors we performed GST-pull down assays with GST-importins
and radioactively labelled IVTT wild-type Znf131, NLS-1m, NLS-2m, and
NLS-1m/NLS-2m mutated Znf131. The autoradiograph shows that wild type
Znf131, NLS-1m, and NLS-2m, but not the NLS-1m/NLS-2m mutated Znf131
binds robustly to GST-importin-α3 and weakly to GST-importin-α2, -α5 and
-α7.
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that these three import receptors do not significantly regulate
Znf131 nuclear import. Individual mutation of either NLS-1 or
NLS-2 alone did not markedly affect binding to the importins
(Fig. 5B), consistent with the nuclear localization of these
mutants (Fig. 3C–E). Moreover, in striking contrast to wild type
Znf131 and Znf131 containing individual mutations at NLS-1
or NLS-2 (NLS-1m and NLS-2m), Znf131 simultaneously
harboring mutations within both NLS-1 and NLS-2 failed to
bind appreciably to any of the GST-importin-α fusion proteins.
Collectively these studies suggest that Znf131 interacts
preferentially with Importin-α3 to achieve nuclear import.
Interestingly, although other proteins such as NF-κB and
RanBP3 also bind Importin-α3 [24,25], to date no known POZ
protein has been shown to bind this particular import receptor.In conclusion, we have characterized two NLSs in the POZ-
ZF protein Znf131. One is a basic classical NLS (NLS-1) and
the other (NLS-2) is an atypical NLS with features of basic
classical NLSs but requiring additional C-terminal amino acid
residues. These nuclear localization signals (NLS-1 and NLS-2)
can function individually to target Znf131 to nuclei. We also
demonstrate a direct interaction between Znf131 and Importin-
α3, suggesting that Znf131 is translocated into the nucleus by
binding this import receptor. The requirement for two
independent NLSs within zinc finger regions was also reported
for the Xenopus laevis transcription factor TFIIIA, which
contains two clusters of zinc fingers that lack the basic residues
characteristic of classical NLSs [22]. Interestingly however, the
two TFIIIA NLSs interacted specifically with importin-α1 and
-α2, and whether they additionally bind importin-α3 or other
importins was not addressed [22].
Our findings constitute only the second report of a mechanism
of nuclear import for a POZ-ZF protein. We recently reported
the mechanism of nuclear trafficking for Kaiso [8], a POZ
transcription factor associated with non-canonical and canonical
Wnt signaling pathways. Our characterization of Kaiso
demonstrated that it possesses only one functional NLS just
upstream of its zinc finger domain [8]. In contrast to the nuclear
translocation of Kaiso, however, Znf131 nuclear trafficking
appears more complex and is regulated by at least two nuclear
targeting signals. Thus, future analyses of the nuclear trafficking
of POZ proteins should account for the possibility of more
complex mechanisms of nuclear entry requiring multiple
targeting sequences.
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